Written by Larissa Ens, RD, CDE
Back in 2018, I worked as a clinical research coordinator on the STEP 1 trial, one of the first studies exploring semaglutide (now marketed as Wegovy in Canada) for weight loss. Since then, my practice has shifted significantly as I no...